prime model
Recently Published Documents


TOTAL DOCUMENTS

78
(FIVE YEARS 20)

H-INDEX

9
(FIVE YEARS 1)

2022 ◽  
Author(s):  
Anna Duenser ◽  
Pooja Singh ◽  
Laurene Alicia Lecaudey ◽  
Christian Sturmbauer ◽  
Craig Albertson ◽  
...  

Studying instances of convergent evolution of novel phenotypes can shed light on the evolutionary constraints that shape morphological diversity. Cichlid fishes from the East African Great Lakes are a prime model to investigate convergent adaptations. However, most studies on cichlid craniofacial morphologies have primarily considered bony structures, while soft tissue adaptations have been less intensely scrutinised. A rare example of an exaggerated soft tissue phenotype is the formation of a snout flap. This tissue flap develops from the upper lip and has evolved in only one cichlid genus from Lake Malawi and one genus from Lake Tanganyika. To investigate the molecular basis of snout flap convergence, we used mRNA sequencing to compare two species with snout flap (Labeotropheus trewavasae and Ophthalmotilapia nasuta) to their close relatives without snout flaps (Tropheops tropheops and Ophthalmotilapia ventralis) from Lake Tanganyika and Malawi. Our analysis revealed a greater complexity of differential gene expression patterns underlying the snout flap in the younger adaptive radiation of Lake Malawi than in the older Lake Tanganyika radiation. We identified 201 genes that were repeatedly differentially expressed between species with and without the snout flap in both lakes, suggesting that the pathway that gives rise to snout flaps is evolutionarily constrained, even though the flaps play very different functions in each species. The convergently expressed genes are involved in proline and hydroxyproline metabolism, which have been linked to human skin and facial deformities. Additionally, we also found enrichment for transcription factor binding sites upstream of differentially expressed genes such as members of the FOX transcription factor family, especially foxf1 and foxa2, which also showed an increased expression in the flapped snout and are linked to nose morphogenesis in mammals, as well as ap4 (tfap4), a transcription factor showing reduced expression in the flapped snout with an unknown role in the development of craniofacial soft tissues. As genes involved in cichlids snout flap development are associated with many human mid-line facial dysmorphologies, our findings imply a conservation of genes involved in mid-line patterning across vastly distant evolutionary lineages of vertebrates.


2021 ◽  
Author(s):  
◽  
Aimee Culverhouse

<p>Drug addiction is characterised by uncontrolled, compulsive drug use despite negative consequences. As this disease has a high social and economic cost, greater attention is required in finding an effective treatment for individuals suffering addiction. Kappa opioid receptor (KOPr) agonists demonstrate anti-addiction effects in the rodent cocaine drug-prime model of reinstatement. Salvinorin A (Sal A), a novel non-nitrogenous KOPr agonist, has demonstrated reduced side-effects compared to traditional agonists. However, its short half-life and duration of action limit clinical development. The design of novel Sal A analogues with improved pharmacokinetics, anti-addiction effects, and reduced side-effects is an important step towards the pharmaceutical development of KOPr agonists. β-Tetrahydropyran Sal B (β-THP Sal B), Mesyl Sal B, ethoxymethyl salvinorin B ether (EOM Sal B), and Ethynyl Sal A (Ethy Sal A) have demonstrated anti-addiction effects by reducing cocaine-seeking behaviour in rats, but their aversive and anxiogenic properties have yet to be examined. Here the conditioned place aversion (CPA) paradigm is used to evaluate aversion and the elevated plus maze (EPM), light/dark test, and open field are utilised to measure anxiety in male Sprague-Dawley rats.  EOM Sal B (0.1 mg/kg, i.p) and Ethy Sal A (0.3 mg/kg, i.p) did not produce aversive effects, whereas the traditional KOPr agonist U50,488 (10 mg/kg, i.p), Sal A (0.3 mg/kg, i.p), and the novel analogue β-THP Sal B (1 mg/kg, i.p) produced significant aversion using the CPA protocol.  In the EPM all the novel analogues, β-THP Sal B, EOM Sal B, Mesyl Sal B, and Ethy Sal, A did not show a reduction in time spent on the open arm. In addition, EOM Sal B showed a significant increase in time spent on the open arm compared with Sal A (0.3 mg/kg, i.p). Sal A (0.3 and 1 mg/kg, i.p) showed significant anxiogenic effects, but the traditional agonist U50,488 did not. In the light/dark test Sal A (1 mg/kg, i.p) showed significant dose dependent anxiogenic effects with significant effects observed at 1 but not 0.3 mg/kg dose. This is in contrast to results observed in the EPM. The novel analogues EOM Sal B and β-THP Sal B demonstrated a non-significant trend toward anxiogenic behaviour in the light/dark test, but U50,488, Mesyl Sal B, and Ethy Sal A did not show significant reductions in time spent in the light box.  KOPr stimulation activates its associated G-proteins, allowing them to interact with several intracellular effectors. Activation of cAMP response element binding protein (CREB) can occur downstream of the KOPr signalling cascade. The phosphorylation of CREB is associated with dysphoria and stress-induced reinstatement of drug-seeking behaviour. An initial attempt to validate CREB assays was made.  The lack of behavioural anxiogenic and aversive side-effects with EOM Sal B, Mesyl Sal B and Ethy Sal A treatment demonstrates that the development of KOPr agonists with desirable effects and reduced side-effects is possible. These novel Sal A agonists provide promising candidates for pharmacotherapy development.</p>


2021 ◽  
Author(s):  
◽  
Aimee Culverhouse

<p>Drug addiction is characterised by uncontrolled, compulsive drug use despite negative consequences. As this disease has a high social and economic cost, greater attention is required in finding an effective treatment for individuals suffering addiction. Kappa opioid receptor (KOPr) agonists demonstrate anti-addiction effects in the rodent cocaine drug-prime model of reinstatement. Salvinorin A (Sal A), a novel non-nitrogenous KOPr agonist, has demonstrated reduced side-effects compared to traditional agonists. However, its short half-life and duration of action limit clinical development. The design of novel Sal A analogues with improved pharmacokinetics, anti-addiction effects, and reduced side-effects is an important step towards the pharmaceutical development of KOPr agonists. β-Tetrahydropyran Sal B (β-THP Sal B), Mesyl Sal B, ethoxymethyl salvinorin B ether (EOM Sal B), and Ethynyl Sal A (Ethy Sal A) have demonstrated anti-addiction effects by reducing cocaine-seeking behaviour in rats, but their aversive and anxiogenic properties have yet to be examined. Here the conditioned place aversion (CPA) paradigm is used to evaluate aversion and the elevated plus maze (EPM), light/dark test, and open field are utilised to measure anxiety in male Sprague-Dawley rats.  EOM Sal B (0.1 mg/kg, i.p) and Ethy Sal A (0.3 mg/kg, i.p) did not produce aversive effects, whereas the traditional KOPr agonist U50,488 (10 mg/kg, i.p), Sal A (0.3 mg/kg, i.p), and the novel analogue β-THP Sal B (1 mg/kg, i.p) produced significant aversion using the CPA protocol.  In the EPM all the novel analogues, β-THP Sal B, EOM Sal B, Mesyl Sal B, and Ethy Sal, A did not show a reduction in time spent on the open arm. In addition, EOM Sal B showed a significant increase in time spent on the open arm compared with Sal A (0.3 mg/kg, i.p). Sal A (0.3 and 1 mg/kg, i.p) showed significant anxiogenic effects, but the traditional agonist U50,488 did not. In the light/dark test Sal A (1 mg/kg, i.p) showed significant dose dependent anxiogenic effects with significant effects observed at 1 but not 0.3 mg/kg dose. This is in contrast to results observed in the EPM. The novel analogues EOM Sal B and β-THP Sal B demonstrated a non-significant trend toward anxiogenic behaviour in the light/dark test, but U50,488, Mesyl Sal B, and Ethy Sal A did not show significant reductions in time spent in the light box.  KOPr stimulation activates its associated G-proteins, allowing them to interact with several intracellular effectors. Activation of cAMP response element binding protein (CREB) can occur downstream of the KOPr signalling cascade. The phosphorylation of CREB is associated with dysphoria and stress-induced reinstatement of drug-seeking behaviour. An initial attempt to validate CREB assays was made.  The lack of behavioural anxiogenic and aversive side-effects with EOM Sal B, Mesyl Sal B and Ethy Sal A treatment demonstrates that the development of KOPr agonists with desirable effects and reduced side-effects is possible. These novel Sal A agonists provide promising candidates for pharmacotherapy development.</p>


2021 ◽  
Vol 13 ◽  
Author(s):  
Shuichi Yanai ◽  
Shogo Endo

Aging is characterized generally by progressive and overall physiological decline of functions and is observed in all animals. A long line of evidence has established the laboratory mouse as the prime model of human aging. However, relatively little is known about the detailed behavioral and functional changes that occur across their lifespan, and how this maps onto the phenotype of human aging. To better understand age-related changes across the life-span, we characterized functional aging in male C57BL/6J mice of five different ages (3, 6, 12, 18, and 22 months of age) using a multi-domain behavioral test battery. Spatial memory and physical activities, including locomotor activity, gait velocity, and grip strength progressively declined with increasing age, although at different rates; anxiety-like behaviors increased with aging. Estimated age-related patterns showed that these functional alterations across ages are non-linear, and the patterns are unique for each behavioral trait. Physical function progressively declines, starting as early as 6 months of age in mice, while cognitive function begins to decline later, with considerable impairment present at 22 months of age. Importantly, functional aging of male C57BL/6J mouse starts at younger relative ages compared to when it starts in humans. Our study suggests that human-equivalent ages of mouse might be better determined on the basis of its functional capabilities.


Fluids ◽  
2021 ◽  
Vol 6 (7) ◽  
pp. 254
Author(s):  
Mitsufumi Asami ◽  
Arata Kimura ◽  
Hideyuki Oka

In general, computational fluid dynamics (CFD) models incur high computational costs when dealing with realistic and complicated flows. In contrast, the mass-consistent flow (MASCON) field model provides a three-dimensional flow field at reasonable computational cost. Unfortunately, some weaknesses in simulating the flow of the wake zone exist because the momentum equations are not considered in the MASCON field model. In the present study, a new set of improved algebraic models to provide initial flow fields for the MASCON field model are proposed to overcome these weaknesses by considering the effect of momentum diffusion in the wake zone. Specifically, these models for the wake region are developed on the basis of the wake models used in well-recognized Gaussian plume models, ADMS-build and PRIME. The MASCON fields provided by the new set of wake zone models are evaluated against wind-tunnel experimental data on flow around a wall-mounted rectangular obstacle. Each MASCON field is compared with the experimental results, focusing on the positions of the vortex core and saddle points of the vortex formed in the near-wake zone and the vertical velocity distribution in the far-wake zone. The set of wake zone models developed in the present study better reproduce the experimental results in both the wake zones compared to the previously proposed models. In particular, the complicated recirculation flow which is formed by the union of the sidewall recirculation zone and the near-wake zone is reproduced by the present wake zone model using the PRIME model that includes the parameterization of the sidewall recirculation zones.


2021 ◽  
Vol 81 (6) ◽  
Author(s):  
S. Biswas ◽  
P. Nayek ◽  
P. Maji ◽  
S. Sahoo

AbstractMotivated by the recent LHCb results of lepton flavour violation on $$b\rightarrow s$$ b → s and $$b\rightarrow c$$ b → c transitions we study the lepton flavour violating (LFV) baryonic decays $${\Lambda }_{b}\rightarrow {\Lambda }l_{i}^{+}l_{j}^{-}$$ Λ b → Λ l i + l j - in non-universal $$Z^{\prime }$$ Z ′ model. We discuss the two-fold decay distribution of $${\Lambda }_{b}\rightarrow {\Lambda }l_{i}^{+}l_{j}^{-}$$ Λ b → Λ l i + l j - decays in terms of transversity amplitudes. From this distribution we study the differential branching ratio and lepton side forward-backward asymmetry in new physics (NP). The predicted values of the observables are very interesting and that might emboss the footprints of NP more aesthetically.


2021 ◽  
Vol 12 ◽  
Author(s):  
Jerzy K. Kulski ◽  
Shingo Suzuki ◽  
Takashi Shiina

The major histocompatibility complex (MHC) on chromosome 6p21 is one of the most single-nucleotide polymorphism (SNP)-dense regions of the human genome and a prime model for the study and understanding of conserved sequence polymorphisms and structural diversity of ancestral haplotypes/conserved extended haplotypes. This study aimed to follow up on a previous analysis of the MHC class I region by using the same set of 95 MHC haplotype sequences downloaded from a publicly available BioProject database at the National Center for Biotechnology Information to identify and characterize the polymorphic human leukocyte antigen (HLA)-class II genes, the MTCO3P1 pseudogene alleles, the indels of transposable elements as haplotypic lineage markers, and SNP-density crossover (XO) loci at haplotype junctions in DNA sequence alignments of different haplotypes across the extended class II region (∼1 Mb) from the telomeric PRRT1 gene in class III to the COL11A2 gene at the centromeric end of class II. We identified 42 haplotypic indels (20 Alu, 7 SVA, 13 LTR or MERs, and 2 indels composed of a mosaic of different transposable elements) linked to particular HLA-class II alleles. Comparative sequence analyses of 136 haplotype pairs revealed 98 unique XO sites between SNP-poor and SNP-rich genomic segments with considerable haplotype shuffling located in the proximity of putative recombination hotspots. The majority of XO sites occurred across various regions including in the vicinity of MTCO3P1 between HLA-DQB1 and HLA-DQB3, between HLA-DQB2 and HLA-DOB, between DOB and TAP2, and between HLA-DOA and HLA-DPA1, where most XOs were within a HERVK22 sequence. We also determined the genomic positions of the PRDM9-recombination suppression sequence motif ATCCATG/CATGGAT and the PRDM9 recombination activation partial binding motif CCTCCCCT/AGGGGAG in the class II region of the human reference genome (NC_ 000006) relative to published meiotic recombination positions. Both the recombination and anti-recombination PRDM9 binding motifs were widely distributed throughout the class II genomic regions with 50% or more found within repeat elements; the anti-recombination motifs were found mostly in L1 fragmented repeats. This study shows substantial haplotype shuffling between different polymorphic blocks and confirms the presence of numerous putative ancestral recombination sites across the class II region between various HLA class II genes.


2021 ◽  
Vol 81 (5) ◽  
Author(s):  
Mariana Frank ◽  
Levent Selbuz ◽  
Ismail Turan

AbstractWe study $$Z^{\prime }$$ Z ′ phenomenology at hadron colliders in an $$U(1)^{\prime }$$ U ( 1 ) ′ extended MSSM. We choose a $$U(1)^{\prime }$$ U ( 1 ) ′ model with a secluded sector, where the tension between the electroweak scale and developing a large enough mass for $$Z^{\prime }$$ Z ′ is resolved by incorporating three additional singlet superfields into the model. We perform a detailed analysis of the production, followed by decays, including into supersymmetric particles, of a $$Z^{\prime }$$ Z ′ boson with mass between 4 and 5.2 TeV, with particular emphasis on its possible discovery. We select three different scenarios consistent with the latest available experimental data and relic density constraints, and concentrate on final signals with $$2\ell +\not \! \! E_{T}$$ 2 ℓ + ⧸ E T , $$4\ell +\not \! \! E_{T}$$ 4 ℓ + ⧸ E T and $$6\ell +\not \! \! E_{T}$$ 6 ℓ + ⧸ E T . Including the SM background from processes with two, three or four vector bosons, we show the likelihood of observing a $$Z^\prime $$ Z ′ boson is not promising for the HL-LHC at 14 TeV. While at 27 and 100 TeV, the situation is more optimistic, and we devise specific benchmark scenarios which could be observed.


2021 ◽  
Author(s):  
Sanjay R Kharche ◽  
Galina Mironova ◽  
Daniel Goldman

Cardiac smooth muscle cell mathematical models are increasingly be- ing used in clinical decision making and drug testing. The cell models also have the potential to assist interpretation and extending of our multi-scale experimental findings. Components of the models interact with each other to regulate model behavior in a non-linear manner. To permit meaningful deployment of the models, it is therefore a necessity to understand the regulatory significance of model components’ parameters on the model’s behavior. In this study, the regulation of mean intra-cellular calcium and mean membrane potential (model behavior) by underlying model parameters (regulators) in a smooth muscle cell mathematical model was quantified using two sensitivity analysis methods. It was found that extracellular electrolytes and gating kinetics are prime model behavior regulators. A representative case relevant to widespread hypertension focusing on the L-type channel’s parameters is presented. This sensitivity analysis will guide our future data driven modelling efforts.


2021 ◽  
Vol 11 ◽  
Author(s):  
Jerzy K. Kulski ◽  
Shingo Suzuki ◽  
Takashi Shiina

The genomic region (~4 Mb) of the human major histocompatibility complex (MHC) on chromosome 6p21 is a prime model for the study and understanding of conserved polymorphic sequences (CPSs) and structural diversity of ancestral haplotypes (AHs)/conserved extended haplotypes (CEHs). The aim of this study was to use a set of 95 MHC genomic sequences downloaded from a publicly available BioProject database at NCBI to identify and characterise polymorphic human leukocyte antigen (HLA) class I genes and pseudogenes, MICA and MICB, and retroelement indels as haplotypic lineage markers, and single-nucleotide polymorphism (SNP) crossover loci in DNA sequence alignments of different haplotypes across the Olfactory Receptor (OR) gene region (~1.2 Mb) and the MHC class I region (~1.8 Mb) from the GPX5 to the MICB gene. Our comparative sequence analyses confirmed the identity of 12 haplotypic retroelement markers and revealed that they partitioned the HLA-A/B/C haplotypes into distinct evolutionary lineages. Crossovers between SNP-poor and SNP-rich regions defined the sequence range of haplotype blocks, and many of these crossover junctions occurred within particular transposable elements, lncRNA, OR12D2, MUC21, MUC22, PSORS1A3, HLA-C, HLA-B, and MICA. In a comparison of more than 250 paired sequence alignments, at least 38 SNP-density crossover sites were mapped across various regions from GPX5 to MICB. In a homology comparison of 16 different haplotypes, seven CEH/AH (7.1, 8.1, 18.2, 51.x, 57.1, 62.x, and 62.1) had no detectable SNP-density crossover junctions and were SNP poor across the entire ~2.8 Mb of sequence alignments. Of the analyses between different recombinant haplotypes, more than half of them had SNP crossovers within 10 kb of LTR16B/ERV3-16A3_I, MLT1, Charlie, and/or THE1 sequences and were in close vicinity to structurally polymorphic Alu and SVA insertion sites. These studies demonstrate that (1) SNP-density crossovers are associated with putative ancestral recombination sites that are widely spread across the MHC class I genomic region from at least the telomeric OR12D2 gene to the centromeric MICB gene and (2) the genomic sequences of MHC homozygous cell lines are useful for analysing haplotype blocks, ancestral haplotypic landscapes and markers, CPSs, and SNP-density crossover junctions.


Sign in / Sign up

Export Citation Format

Share Document